Johnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorisation in early 2021.
J&J also said it had committed more than $1 billion of investment along with US agency Biomedical Advanced Research and Development Authority to co-fund vaccine research.
More Stories
Debt Ceiling Deal Wins House Approval
G7 Agrees On Ukraine Jets, China ‘Economic Coercion’ Statement
Turkey Votes In Pivotal Elections That Could End Erdogan’s 20-Year Rule
Wagner Group Signals It Will Stay In Bakhmut After Prigozhin Threatened To Pull Forces
Anti-Monarchists Released From Custody After King Charles’ Coronation
King Charles And Queen Camilla Crowned In Historic Ceremony
Russia’s Prigozhin Says Wagner Fighters Will Quit Bakhmut To ‘Lick Our Wounds’
Sudan Conflict Could Prompt 800,000 People To Flee – UN
Theranos Founder Holmes Stays Out Of Prison With Appeal
Death Toll In Kenyan Starvation Cult Rises To 73 – Police
Africa.com And Standard Bank Group Release The 2023 Definitive List Of Women CEOs
New York Grand Jury Votes To Indict Trump